- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01465893
Effect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography
November 21, 2011 updated by: Masoud Etemadifar, Isfahan University of Medical Sciences
The Investigation Effect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography
This study examines the effect of vitamin D on Retinal changes in patient with optic Neuritis.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tehran, Iran, Islamic Republic of
- Recruiting
- Isfahan Medical University
-
Contact:
- mehri salari, neurology resident
- Phone Number: 09124972186
- Email: mehri.salari@yahoo.com
-
Principal Investigator:
- masoud etemadifar, neurology proffesor
-
Principal Investigator:
- mehri salari, neurology resident
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 50 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 15-50 years
- no history of demyelinative events
- level of vitamin d below 20 ng/ml
- no pass 10-32 day from starting symptom
Exclusion Criteria:
- using vitamin D supplement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: vitamin D
vitamin d 50000/w
|
vitamin D ,50000 unit /week
|
|
Sham Comparator: control
follow up
|
do not receive anything
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
measurement Retinal nerve fiber layer (RNFL) thickness by OCT
Time Frame: 10-32 days after optic neuritis
|
10-32 days after optic neuritis
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
measurement RNFL thickness by OCT
Time Frame: 6 months after optic neuritis
|
6 months after optic neuritis
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2011
Primary Completion (Anticipated)
July 1, 2012
Study Completion (Anticipated)
December 1, 2012
Study Registration Dates
First Submitted
October 28, 2011
First Submitted That Met QC Criteria
November 4, 2011
First Posted (Estimate)
November 6, 2011
Study Record Updates
Last Update Posted (Estimate)
November 22, 2011
Last Update Submitted That Met QC Criteria
November 21, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Eye Diseases
- Neuromuscular Diseases
- Peripheral Nervous System Diseases
- Optic Nerve Diseases
- Cranial Nerve Diseases
- Neuritis
- Optic Neuritis
- Physiological Effects of Drugs
- Micronutrients
- Bone Density Conservation Agents
- Calcium-Regulating Hormones and Agents
- Vitamin D
- Cholecalciferol
- Vitamins
- Ergocalciferols
Other Study ID Numbers
- isfahan medical university
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Optic Neuritis
-
Medical University of ViennaUnknownOptic; Neuritis, With DemyelinationAustria
-
BiogenCompletedAcute Optic NeuritisSweden, Australia, Italy, Spain, United Kingdom, Germany, Belgium, Denmark, Hungary, Czech Republic, Canada
-
Novartis PharmaceuticalsTerminatedAcute Demylelinating Optic NeuritisUnited States, Spain
-
BiogenCompletedAcute Optic NeuritisSweden, Spain, United Kingdom, Germany, Canada, Denmark, Hungary, Belgium, Czechia, Australia, Italy
-
Accure TherapeuticsSimbec ResearchCompletedOptic Neuritis | Optic; Neuritis, With DemyelinationUnited Kingdom
-
First Affiliated Hospital of Guangxi Medical UniversityTerminated
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
University of ZurichUniversity Hospital, Zürich; Swiss MS Society; Data Management, Clinical Trials...TerminatedAcute Autoimmune Inflammatory Optic NeuritisSwitzerland
-
Chinese PLA General HospitalRecruiting
Clinical Trials on Vitamin D
-
University of Ilorin Teaching HospitalMayo ClinicNot yet recruitingProstate Cancer (Adenocarcinoma) | Vitamin D on Tumor Response and Inflammatory MarkersNigeria
-
PfizerTerminated
-
Wroclaw University of Health and Sport SciencesCompletedAthletes | Football Players | Exercise Physiology | Vitamin D Deficiency (10 ng/mL to 30 ng/mL)Poland
-
Universidad Autónoma Benito Juárez de OaxacaNational Council of Science and Technology, MexicoCompletedObesity | Muscle Weakness | Vitamin D Deficiency | Sarcopenia | Aging | Sarcopenic Obesity | Obesity (Disorder) | Sarcopenia in Elderly | Muscle Mass | Functional Decline | Age-Related Loss of Skeletal Muscle Mass | Older Adults (65 Years and Older) | Muscle Strengh | Vitamin D 25-Hydroxylase DeficiencyMexico
-
Umeå UniversityRegion SkaneCompleted
-
Bangladesh Medical UniversityEnrolling by invitationHypovitaminosis D | Major Depressive Disorder (MDD)Bangladesh
-
Karadeniz Technical UniversityActive, not recruitingThose Who Provided Written Informed Consent | Female Gender | Aged 18 Years and Older | Hypothyroidism Disease | Serum Vitamin d < 30 ng/dlTurkey (Türkiye)
-
Khon Kaen UniversityCompletedEndometriosis | Vitamin D Status | Vitamin D Deficiency/InsufficiencyThailand
-
Fundación Cardiovascular de ColombiaUniversidad Industrial de Santander; Farma de Colombia SACompletedVitamin D Deficiency | Overweight and Obesity | Overweight AdolescentsColombia
-
The Jerzy Kukuczka Academy of Physical Education...RecruitingVitamin D Deficiency/Insufficiency | Vitamin D 25-Hydroxylase DeficiencyPoland